News

November 2018

Viewing posts from November , 2018

Nextremity Solutions, Inc. Ranked 331st Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500™

Attributes 246.6% Percent Revenue Growth to a high achieving team collaborating with surgeons to develop and commercialize innovative products for the benefit of patients worldwide.

 Warsaw, Indiana, November 16, 2018 — Nextremity Solutions, Inc., a strategic commercialization organization with a focus on the musculoskeletal space, located in “The Orthopedic Capital of the World,” Warsaw, Ind., today announced it ranked 331st on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in North America. Nextremity Solutions, Inc. grew 246.6% percent during this period.

Dan Stichter, Chief Financial Officer for Nextremity Solutions, credits an innovative team, critical surgeon relationships, and strong manufacturing and distribution partnerships with the company’s 246.6% revenue growth. Stichter said, “Since Nextremity’s founding in 2007, the company has collaborated with surgeons to develop innovative solutions to unmet clinical needs. We are excited to see these solutions being rapidly adopted in the marketplace.  Nextremity looks forward to rewarding its investors with a growing legacy of innovation for many years to come.”

“We are honored to receive this ranking as part of Deloitte’s Technology Fast 500. Every member of our team has worked with excellence to ensure that the technology we develop gets into the hands of the surgeons we serve. Through strategic partnerships we have developed over the years, we are better able to do more of what we do best; more profitably every day,” commented Rod Mayer, President & CEO for Nextremity Solutions.

“Congratulations to the Deloitte 2018 Technology Fast 500 winners on this impressive achievement,” said Sandra Shirai, vice chairman, Deloitte LLP, and U.S. technology, media and telecommunications leader. “These companies are innovators who have converted their disruptive ideas into products, services and experiences that can captivate new customers and drive remarkable growth.”

Mohana Dissanayake, partner, Deloitte & Touche LLP, and Industry Leader for technology, media and telecommunications, within Deloitte’s audit and assurance practice. “This year’s ranking demonstrates what is likely a national phenomenon, where many companies from all parts of America are transforming the way we do business by combining breakthrough research and development, entrepreneurship and rapid growth.”

Overall, 2018 Technology Fast 500™ companies achieved revenue growth ranging from 143 percent to 77,260 percent from 2014 to 2017, with median growth of 412 percent.

 

About Deloitte’s 2018 Technology Fast 500™

Deloitte’s Technology Fast 500 provides a ranking of the fastest growing technology, media, telecommunications, life sciences and energy tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2014 to 2017.

In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least $50,000 USD, and current-year operating revenues of at least $5 million USD. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.

About Nextremity Solutions, Inc.

Nextremity Solutions, Inc. is a privately held strategic commercialization organization with a focus on the musculoskeletal space, offering innovative solutions and Revenue Ready® products for various musculoskeletal applications and for the benefit of our industry partners. The Company’s procedure-ready, sterile implant systems include uniquely precise, proprietary technology designed to achieve repeatable and superior clinical outcomes.

About Deloitte

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the “Deloitte” name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about their global network of member firms.